Literature DB >> 15336258

Synthesis, stereochemical determination and biochemical characterization of the enantiomeric phosphate esters of the novel immunosuppressive agent FTY720.

Jeffrey J Hale1, Lin Yan, William E Neway, Richard Hajdu, James D Bergstrom, James A Milligan, Gan-Ju Shei, Gary L Chrebet, Rosemary A Thornton, Deborah Card, Mark Rosenbach, Suzanne Mandala.   

Abstract

The novel immunosuppressive agent FTY720 (1) is phosphorylated in vivo in a variety of species yielding an active metabolite that is an agonist of four of the five known G-protein-coupled sphingosine-1-phosphate (S1P) receptors. A synthesis amenable to producing gram quantities of the stereoisomeric phosphate esters, a determination of their absolute stereochemistry via an enantioselective synthesis and their characterization as S1P receptor agonists and antagonists is reported.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336258     DOI: 10.1016/j.bmc.2004.07.020

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

1.  Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.

Authors:  S M Dudek; S M Camp; E T Chiang; P A Singleton; P V Usatyuk; Y Zhao; V Natarajan; J G N Garcia
Journal:  Cell Signal       Date:  2007-04-06       Impact factor: 4.315

2.  Chiral vinylphosphonate and phosphonate analogues of the immunosuppressive agent FTY720.

Authors:  Xuequan Lu; Chaode Sun; William J Valentine; E Shuyu; Jianxiong Liu; Gabor Tigyi; Robert Bittman
Journal:  J Org Chem       Date:  2009-04-17       Impact factor: 4.354

3.  Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning.

Authors:  Molly E Ogle; Lauren S Sefcik; Anthony O Awojoodu; Nathan F Chiappa; Kevin Lynch; Shayn Peirce-Cottler; Edward A Botchwey
Journal:  Acta Biomater       Date:  2014-08-13       Impact factor: 8.947

4.  Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist.

Authors:  Takahide Nishi; Shojiro Miyazaki; Toshiyasu Takemoto; Keisuke Suzuki; Yukiko Iio; Katsuyoshi Nakajima; Takashi Ohnuki; Yumi Kawase; Futoshi Nara; Shinichi Inaba; Takashi Izumi; Hiroshi Yuita; Keiko Oshima; Hiromi Doi; Ryotaku Inoue; Wataru Tomisato; Takashi Kagari; Takaichi Shimozato
Journal:  ACS Med Chem Lett       Date:  2011-03-02       Impact factor: 4.345

5.  Sphingosine-1-Phosphate Receptor-3 Supports Hematopoietic Stem and Progenitor Cell Residence Within the Bone Marrow Niche.

Authors:  Molly E Ogle; Claire E Olingy; Anthony O Awojoodu; Anusuya Das; Rafael A Ortiz; Hoi Yin Cheung; Edward A Botchwey
Journal:  Stem Cells       Date:  2017-01-19       Impact factor: 6.277

6.  (7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic Acids as S1P1 Functional Antagonists.

Authors:  Daniel J Buzard; Luis Lopez; Jeanne Moody; Andrew Kawasaki; Thomas O Schrader; Michelle Kasem; Ben Johnson; Xiuwen Zhu; Lars Thoresen; Sun Hee Kim; Tawfik Gharbaoui; Dipanjan Sengupta; Lorene Calvano; Ashwin Krishnan; Yinghong Gao; Graeme Semple; Jeff Edwards; Jeremy Barden; Michael Morgan; Khawja Usmani; Chuan Chen; Abu Sadeque; Weichao Chen; Ronald J Christopher; Jayant Thatte; Lixia Fu; Michelle Solomon; Kevin Whelan; Hussien Al-Shamma; Joel Gatlin; Ibragim Gaidarov; Todd Anthony; Minh Le; David J Unett; Scott Stirn; Anthony Blackburn; Dominic P Behan; Robert M Jones
Journal:  ACS Med Chem Lett       Date:  2014-11-25       Impact factor: 4.345

7.  Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.

Authors:  Daniel J Buzard; Sun Hee Kim; Luis Lopez; Andrew Kawasaki; Xiuwen Zhu; Jeanne Moody; Lars Thoresen; Imelda Calderon; Brett Ullman; Sangdon Han; Juerg Lehmann; Tawfik Gharbaoui; Dipanjan Sengupta; Lorene Calvano; Antonio Garrido Montalban; You-An Ma; Carleton Sage; Yinghong Gao; Graeme Semple; Jeff Edwards; Jeremy Barden; Michael Morgan; Weichao Chen; Khawja Usmani; Chuan Chen; Abu Sadeque; Ronald J Christopher; Jayant Thatte; Lixia Fu; Michelle Solomon; David Mills; Kevin Whelan; Hussien Al-Shamma; Joel Gatlin; Minh Le; Ibragim Gaidarov; Todd Anthony; David J Unett; Anthony Blackburn; Jaimie Rueter; Scott Stirn; Dominic P Behan; Robert M Jones
Journal:  ACS Med Chem Lett       Date:  2014-11-04       Impact factor: 4.345

8.  Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist.

Authors:  Ran Zhu; Ashley H Snyder; Yugesh Kharel; Lisa Schaffter; Qin Sun; Perry C Kennedy; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2007-11-10       Impact factor: 7.446

9.  Sphingosine 1-phosphate pKa and binding constants: intramolecular and intermolecular influences.

Authors:  Mor M Naor; Michelle D Walker; James R Van Brocklyn; Gabor Tigyi; Abby L Parrill
Journal:  J Mol Graph Model       Date:  2007-03-14       Impact factor: 2.518

10.  FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology.

Authors:  Kunitomo Adachi; Kenji Chiba
Journal:  Perspect Medicin Chem       Date:  2007-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.